Wasserman PG, Savargaonkar P (2001) Paragangliomas: classification, pathology, and differential diagnosis. Otolaryngol Clin North Am 34(5):845–862. https://doi.org/10.1016/s0030-6665(05)70351-0

Article  CAS  PubMed  Google Scholar 

Mete O, Asa SL, Gill AJ, Kimura N, de Krijger RR, Tischler AS (2022) Overview of the 2022 WHO classification of paragangliomas and pheochromocytomas. Endocr Pathol 33(1):90–114. https://doi.org/10.1007/s12022-022-09704-6

Article  CAS  PubMed  Google Scholar 

Amemiya T, Kadoya M (1980) Paraganglioma in the orbit. J Cancer Res Clin Oncol 96(2):169–179. https://doi.org/10.1007/bf00405502

Article  CAS  PubMed  Google Scholar 

Lertakyamanee P, Srinivasan A, De Lott LB, Trobe JD (2015) Papilledema and vision loss caused by jugular paragangliomas. J Neuroophthalmol 35(4):364–370. https://doi.org/10.1097/wno.0000000000000281

Article  PubMed  Google Scholar 

Singh N, Chaudhri K, Catt C (2023) Hypertensive retinopathy in the paediatric setting. Med J Aust 218(9):392–393. https://doi.org/10.5694/mja2.51929

Article  PubMed  Google Scholar 

Petkou D, Petropoulos IK, Kordelou A, Katsimpris JM (2008) Severe bilateral hypertensive retinopathy and optic neuropathy in a patient with pheochromocytoma. Klin Monatsbl Augenheilkd 225(5):500–503. https://doi.org/10.1055/s-2008-1027355

Article  CAS  PubMed  Google Scholar 

Vohra V, Chawla H, Malik PK (2016) Bilateral exudative retinal detachment in a case of paraganglioma. J Clin Ophthalmol Res 4(2):92–95. https://doi.org/10.4103/2320-3897.183720

Article  Google Scholar 

Mazza A, Armigliato M, Marzola MC, Schiavon L, Montemurro D, Vescovo G et al (2014) Anti-hypertensive treatment in pheochromocytoma and paraganglioma: current management and therapeutic features. Endocrine 45:469–478. https://doi.org/10.1007/s12020-013-0007-y

Article  CAS  PubMed  Google Scholar 

Young WF Jr (2006) Paragangliomas: clinical overview. Ann N Y Acad Sci 1073:21–29. https://doi.org/10.1196/annals.1353.002

Article  CAS  PubMed  Google Scholar 

Alface MM, Moniz P, Jesus S, Fonseca C (2015) Pheochromocytoma: clinical review based on a rare case in adolescence. BMJ Case Rep bcr2015211184. https://doi.org/10.1136/bcr-2015-211184

Article  Google Scholar 

Reisch N, Peczkowska M, Januszewicz A, Neumann HP (2006) Pheochromocytoma: presentation, diagnosis and treatment. J Hypertens 24(12):2331–2339. https://doi.org/10.1097/01.hjh.0000251887.01885.54

Article  CAS  PubMed  Google Scholar 

Kudva YC, Sawka AM, Young WF Jr (2003) The laboratory diagnosis of adrenal pheochromocytoma: the Mayo clinic experience. J Clin Endocrinol Metab 88(10):4533–4539. https://doi.org/10.1210/jc.2003-030720

Article  CAS  PubMed  Google Scholar 

Eisenhofer G, Peitzsch M (2014) Laboratory evaluation of pheochromocytoma and paraganglioma. Clin Chem 60(12):1486–1499. https://doi.org/10.1373/clinchem.2014.224832

Article  CAS  PubMed  Google Scholar 

Lenders JWM, Duh QY, Eisenhofer G, Gimenez-Roqueplo AP, Grebe SKG, Murad MH et al (2014) Pheochromocytoma and paraganglioma: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 99(6):1915–1942. https://doi.org/10.1210/jc.2014-1498

Article  CAS  PubMed  Google Scholar 

Sawka AM, Jaeschke R, Singh RJ, Young WF Jr (2003) A comparison of biochemical tests for pheochromocytoma: measurement of fractionated plasma metanephrines compared with the combination of 24-hour urinary metanephrines and catecholamines. J Clin Endocrinol Metab 88(2):553–558. https://doi.org/10.1210/jc.2002-021251

Article  CAS  PubMed  Google Scholar 

McDermott S, McCarthy CJ, Blake MA (2015) Images of pheochromocytoma in adrenal glands. Gland Surg 4(4):350–358. https://doi.org/10.3978/j.issn.2227-684x.2014.11.06

Article  PubMed  PubMed Central  Google Scholar 

Brink I, Hoegerle S, Klisch J, Bley TA (2005) Imaging of pheochromocytoma and paraganglioma. Fam Cancer 4(1):61–68. https://doi.org/10.1007/s10689-004-2155-y

Article  CAS  PubMed  Google Scholar 

Banerjee A, Nayak B, Verma G, Parija S (2020) Resolution of grade IV hypertensive retinopathy in an adult with pheochromocytoma: post-tumor resection. BMJ Case Rep CP 13(2):e231245. https://doi.org/10.1136/bcr-2019-231245

Article  Google Scholar 

Čtvrtlík F, Koranda P, Schovanek J, Skarda J, Hartmann I, Tüdös Z (2018) Current diagnostic imaging of pheochromocytomas and implications for therapeutic strategy. Exp Ther Med 15(4):3151–3160. https://doi.org/10.3892/etm.2018.5871

Article  CAS  PubMed  PubMed Central  Google Scholar 

Di Marco E, Aiello F, Lombardo M, Di Marino M, Missiroli F et al (2022) A literature review of hypertensive retinopathy: systemic correlations and new technologies. Eur Rev Med Pharmacol Sci 26(18):6424–6443. https://doi.org/10.26355/eurrev_202209_29742

Article  PubMed  Google Scholar 

Taïeb D, Timmers HJ, Hindié E, Guillet BA, Neumann HP, Walz MK et al (2012) EANM 2012 guidelines for radionuclide imaging of pheochromocytoma and paraganglioma. Eur J Nucl Med Mol Imaging 39(12):1977–1995. https://doi.org/10.1007/s00259-012-2215-8

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ilias I, Chen CC, Carrasquillo JA, Whatley M, Ling A, Lazurova I et al (2008) Comparison of 6-[18F]-fluorodopamine PET with 123I-MIBG and 111In-pentetreotide scintigraphy in localization of nonmetastatic and metastatic pheochromocytoma. J Nucl Med 49(10):1613–1619. https://doi.org/10.2967/jnumed.108.052373

Article  PubMed  Google Scholar 

Timmers HJ, Eisenhofer G, Carrasquillo JA, Chen CC, Whatley M, Ling A et al (2009) Use of 6-[18F]-fluorodopamine positron emission tomography (PET) as first-line investigation for diagnosis and localization of non-metastatic and metastatic pheochromocytoma. Clin Endocrinol (Oxf) 71(1):11–17. https://doi.org/10.1111/j.1365-2265.2008.03496.x

Article  PubMed  Google Scholar 

Timmers HJLM, Chen CC, Carrasquillo JA, Whatley M, Ling A, Havekes B et al (2009) Comparison of 18F-fluoro-L-DOPA, 18F-fluorodeoxyglucose, and 18F-fluorodopamine PET and 123I-MIBG scintigraphy in the localization of pheochromocytoma and paraganglioma. J Clin Endocrinol Metab 94(12):4757–4767. https://doi.org/10.1210/jc.2009-1248

Article  CAS  PubMed  PubMed Central  Google Scholar 

Fiebrich HB, Brouwers AH, Kerstens MN, Pijl ME, Kema IP, de Jong JR et al (2009) 6-[18F]-fluoro-L-dihydroxyphenylalanine positron emission tomography is superior to conventional imaging with 123I-MIBG scintigraphy, CT, and MRI in localizing tumors causing catecholamine excess. J Clin Endocrinol Metab 94(10):3922–3930. https://doi.org/10.1210/jc.2009-0902

Article  CAS  PubMed  Google Scholar